Summary
The pharmacokinetics of ranitidine was investigated in 11 patients with acute or end stage renal failure during haemofiltration. Each patient received 50 mg ranitidine i.v.
The mean distribution and elimination half lives were 0.13 and 2.57 h, respectively. The total body clearance (CL) and volume of distribution (Vz) were 298 ml·min−1 (5.19 ml·min−1·kg−1) and 1.081·kg−1, respectively. About 17.1% of the administered dose was removed by haemofiltration (in approximately 201 filtrate). Five of the patients still had some urine output and they excreted 0.1 to 11.8% of the dose in urine in 24 h. The haemofiltration clearance was 66.9 ml·min−1 at a filtrate flow rate of 86 ml·min−1, corresponding to a mean sieving coefficient of 0.78 (n=6). As plasma concentrations were still in an effective range after haemofiltration, dose supplementation is not recommended.
This is a preview of subscription content, log in via an institution to check access.
References
Bogues K, Dixon GT, Fowler P, Jenner WN, Maconochie JG, Martin LE, Willoughby BA (1981) Pharmacokinetics and bioavailability of ranitidine in humans. Br J Pharmacol 73: 275–276
Carey PF, Martin LE (1979) A high performance liquid chromatography method for the determination of ranitidine in plasma. J Liquid Chromatography 2: 1291–1303
Chau N, Zech PY, Pozet N, Hadj-Aissa A (1982) Ranitidine kinetics in normal subjects. Clin Pharmacol Ther 31: 770–774
Dammann HG, Kather H, Augustin HJ, Simon B (1980) Untersuchung über die Wirkungsdauer von Ranitidin. Dtsch Med Wochenschr 105: 603–605
Dammann HG, Müller P, Kather H, Simon B (1981) The new histamine H2-receptor antagonist ranitidine. Res Exp Med 178: 151–154
Domschke W, Lux G, Domschke S (1980) Furan H2-antagonist ranitidine inhibits pentagastrin-stimulated gastric secretion stronger than cimetidine. Gastroenterology 79: 1267–1271
Garg DC, Weidler DJ, Baltodano N, Eshelman FN (1981) Pharmacokinetics of ranitidine, a new histamine H2-receptor blocker. Clin Pharmacol Ther 29: 247–248 (abstract)
Garg DC, Baltodano N, Perez GO, Oster JR, Jallad NS, Weidler DJ (1985) Pharmacokinetics of ranitidine after intravenous administration in hemodialysis patients. Pharmacology 31: 189–193
Gladziwa U, Klotz U, Krishna DR, Schmitt H, Glöckner WM, Mann H (1988) Pharmacokinetics and dynamics of famotidine in patients with renal failure. Br J Clin Pharmacol 26 (in press)
Golper TA, Wedel SK, Kaplan AA, Saad AM, Donta ST, Paganini EP (1985) Drug removal during continuous arteriovenous hemofiltration: Theory and clinical observations. Int J Artif Org 8: 307–312
McFadyen ML, Folb PI, Miller R, Keeton GR, Marks IN (1983) Pharmacokinetics of ranitidine in patients with chronic renal failure. Eur J Clin Pharmacol 25: 347–351
McGonigle RJS, Williams LC, Amphlett GE, England RJ, Parsons V (1982) The pharmacokinetics of ranitidine in renal disease. In: Misiewiez JJ, Wormsley KG (eds) The clinical use of ranitidine. Medicine Publishing Foundation, Oxford, pp 41–47
McNeil JJ, Mihaly GW, Anderson A, Marshall AW, Smallwood RA, Louis WJ (1981) Pharmacokinetics of the H2-receptor antagonist ranitidine in man. Br J Clin PHarmacol 12: 411–415
Roberts AP, Harrison C, Dixon GT, Curtis JR (1983) Plasma ranitidine concentrations after intravenous administration in normal volunteers and hemodialysis patients. Postgrad Med J 59: 25–27
Roberts CJC (1984) Clinical pharmacokinetics of ranitidine. Clin Pharmacokinet 9: 211–221
Savarino V, Mela GS, Scalabrini P, Di Timoteo E, Magnolia MR, Percario G, Celle G (1986) Famotidine and ranitidine control of 24 h intragastric acidity after single bed time administration: A study using continuous pH monitoring. Br J Clin Pharmacol 22: 749–750
Sica DA, Harford A, Comstock T, Eshelman F, Pierpaoli S (1985) Ranitidine (R) pharmacokinetics in chronic hemodialysis (H). Clin Pharmacol Ther 37: 229 (abstract)
Sica DA, Comstock T, Harford A, Eshelman F (1987) Ranitidine pharmacokinetics in continuous ambulatory peritoneal dialysis. Eur J Clin Pharmacol 32: 587–591
Van Hecken AM, Tjandramaga TB, Mullie A, Verbesselt R, DeSchepper PJ (1982) Ranitidine: Single dose pharmacokinetics and absolute bioavailability in man. Br J Clin Pharmacol 14: 195–200
Yamaoka K, Tanigawara Y, Nakagawa T, Uno T (1981) A pharmacokinetic analysis program (MULTI) for microcomputer. J Pharm Dyn 4: 879–885
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gladziwa, U., Krishna, D.R., Klotz, U. et al. Pharmacokinetics of ranitidine in patients undergoing haemofiltration. Eur J Clin Pharmacol 35, 427–430 (1988). https://doi.org/10.1007/BF00561377
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00561377